Publicacións (26) Publicacións nas que participase algún/ha investigador/a

2018

  1. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  2. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  3. An rna toolbox for cancer immunotherapy

    Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767

  4. Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: The role of occult pre-existing autoimmunity

    Haematologica

  5. CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes

    Cancer Immunology Research, Vol. 6, Núm. 1, pp. 69-78

  6. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV

  7. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

    Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319

  8. Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

    OncoImmunology, Vol. 7, Núm. 1

  9. Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

    OncoImmunology, Vol. 7, Núm. 2

  10. Epistatic oncogenic interactions determine cancer susceptibility to immunotherapy

    Cancer Discovery, Vol. 8, Núm. 7, pp. 794-796

  11. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

  12. ICAM-1-LFA-1 dependent CD8+ T-lymphocyte aggregation in tumor tissue prevents recirculation to draining lymph nodes

    Frontiers in Immunology, Vol. 9, Núm. SEP

  13. Immunodivergence in Metastatic Colorectal Cancer

    Cancer Cell

  14. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect

    Trends in Immunology, Vol. 39, Núm. 8, pp. 644-655

  15. Immunotherapy of hepatocellular carcinoma: Facts and hopes

    Clinical Cancer Research, Vol. 24, Núm. 7, pp. 1518-1524

  16. Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies

    Blood, Vol. 131, Núm. 1, pp. 49-57

  17. International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain

    Cancer Immunology, Immunotherapy

  18. Introducción

    Guía inmunotoxicidad: diagnóstico y manejo de los efectos secundarios asociados a inmunoterapia en oncología (EUNSA. Ediciones Universidad de Navarra, S.A.), pp. 12-17

  19. Introducing a new series: Immunotherapy facts and hopes

    Clinical Cancer Research

  20. Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation

    Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811